IFNG and neoplasm: Tumor cells and tumor-infiltrating T lymphocytes compete for glucose, and massive glucose consumption by tumor cells change the metabolic microenvironment of T lymphocytes, inhibit IFN-γ, and promote tumor progression and immune escape [16].